| Conformational flexibility determines selectivity and antibacterial, antiplasmodial, and anticancer potency of cationic α-helical peptides LS Vermeer, Y Lan, V Abbate, E Ruh, TT Bui, LJ Wilkinson, T Kanno, ... Journal of Biological Chemistry 287 (41), 34120-34133, 2012 | 96 | 2012 |
| Single-cell RNA-sequencing and metabolomics analyses reveal the contribution of perivascular adipose tissue stem cells to vascular remodeling W Gu, WN Nowak, Y Xie, A Le Bras, Y Hu, J Deng, S Issa Bhaloo, Y Lu, ... Arteriosclerosis, thrombosis, and vascular biology 39 (10), 2049-2066, 2019 | 84 | 2019 |
| β-Galactooligosaccharide in conjunction with low FODMAP diet improves irritable bowel syndrome symptoms but reduces fecal bifidobacteria B Wilson, M Rossi, T Kanno, GC Parkes, S Anderson, AJ Mason, ... Official journal of the American College of Gastroenterology| ACG 115 (6 …, 2020 | 60 | 2020 |
| Opportunistic bacteria confer the ability to ferment prebiotic starch in the adult cystic fibrosis gut Y Wang, LEX Leong, RL Keating, T Kanno, GCJ Abell, FM Mobegi, ... Gut Microbes 10 (3), 367-381, 2019 | 48 | 2019 |
| Cervicovaginal microbiota and metabolome predict preterm birth risk in an ethnically diverse cohort F Flaviani, NL Hezelgrave, T Kanno, EM Prosdocimi, E Chin-Smith, ... JCI insight 6 (16), 2021 | 39 | 2021 |
| Models of breast morphogenesis based on localization of stem cells in the developing mammary lobule G Honeth, T Schiavinotto, F Vaggi, R Marlow, T Kanno, I Shinomiya, ... Stem Cell Reports 4 (4), 699-711, 2015 | 31 | 2015 |
| Divergent relationships between fecal microbiota and metabolome following distinct antibiotic-induced disruptions JM Choo, T Kanno, NMM Zain, LEX Leong, GCJ Abell, JE Keeble, ... Msphere 2 (1), 10.1128/msphere. 00005-17, 2017 | 29 | 2017 |
| Rifampin- or Capreomycin-Induced Remodeling of the Mycobacterium smegmatis Mycolic Acid Layer Is Mitigated in Synergistic Combinations with Cationic … DDKW Man, T Kanno, G Manzo, BD Robertson, JKW Lam, AJ Mason Msphere 3 (4), 10.1128/msphere. 00218-18, 2018 | 11 | 2018 |
| Randomized, double-blind, placebo (PBO)-controlled, single-and multiple-dose phase 1 study of VE202, a defined bacterial consortium for treatment of IBD: safety and … J Silber, J Norman, T Kanno, E Crossette, R Szabady, R Menon, M Marko, ... Inflammatory Bowel Diseases 28 (Supplement_1), S65-S66, 2022 | 8 | 2022 |
| Dop53 clinical, endoscopic, histological and biomarker activity following treatment with the gut-selective, pan-JAK inhibitor TD-1473 in moderately to severely active … W Sandborn, D Nguyen, B Ferslew, LY Hao, T Kanno, L Tomsho, D Boyle, ... Journal of Crohn's and Colitis 13 (Supplement_1), S060-S061, 2019 | 8* | 2019 |
| Faecal and urine metabolites, but not gut microbiota, may predict response to low FODMAP diet in irritable bowel syndrome B Wilson, T Kanno, R Slater, M Rossi, PM Irving, MC Lomer, C Probert, ... Alimentary Pharmacology & Therapeutics 58 (4), 404-416, 2023 | 6 | 2023 |
| High prevalence and heterogeneity of emergence of BRCA reversion mutations at progression on niraparib treatment in BRCA-mutant metastatic castration … K Urtishak, G Attard, T Kanno, S Thomas, GE Mason, B Espina, E Zhu, ... Cancer Research 82 (12_Supplement), 4133-4133, 2022 | 6 | 2022 |
| TEAD Inhibitors Sensitize KRASG12C Inhibitors via Dual Cell Cycle Arrest in KRASG12C-Mutant NSCLC SL Tammaccaro, P Prigent, JC Le Bail, O Dos-Santos, L Dassencourt, ... Pharmaceuticals 16 (4), 553, 2023 | 4 | 2023 |
| Low FODMAP diet & prebiotic β-galactooligosaccharides improve irritable bowel syndrome and response to low FODMAP is predicted by urine and faecal metabolites: a randomised … B Wilson, M Rossi, T Kanno, R Hough, C Probert, G Parkes, S Anderson, ... Proceedings of the Nutrition Society 79 (OCE1), E19, 2020 | 4 | 2020 |
| Rifampicin or capreomycin induced remodelling of the Mycobacterium smegmatis mycolic acid layer is mitigated in synergistic combinations with cationic … DDKW Man, T Kanno, G Manzo, BD Robertson, JKW Lam, AJ Mason bioRxiv, 269324, 2018 | 4 | 2018 |
| PWE-126 Low fodmap diet effect on IBS gastrointestinal microbiome and metabolites and prediction of response B Wilson, M Rossi, T Kanno, R Hough, C Probert, P Irving, AJ Mason, ... Gut 67 (Suppl 1), A181-A182, 2018 | 3 | 2018 |
| Mo1049-Low Fodmap Diet & Prebiotic β-Galactooligosaccharides Improve Irritable Bowel Syndrome with no Impact on α-Diversity and Response to Low Fodmap Diet is Predicted by … BJ Wilson, M Rossi, T Kanno, R Hough, C Probert, GC Parkes, Q Aziz, ... Gastroenterology 154 (6), S-683, 2018 | 1 | 2018 |
| Elafin in cervicovaginal fluid as a predictor of spontaneous preterm birth NL Hezelgrave, ECC Smith, PT Seed, T Kanno, M Molokhia, AJ Mason, ... BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY 125, 13-14, 2018 | 1 | 2018 |
| The Impact of Long-Term Macrolide Exposure on the Gut Microbiome and Its Implications for Metabolic Control JM Choo, AM Martin, SL Taylor, E Sun, FM Mobegi, T Kanno, A Richard, ... Microbiology spectrum 11 (4), e00831-23, 2023 | | 2023 |
| 80P Dual cell cycle arrest in KRAS mutant cell lines by co-inhibition of MAPK and Hippo-YAP1 pathways SL Tammaccaro, P Prigent, JC Le Bail, O Dos Santos, L Dassencourt, ... Annals of Oncology 33, S1408, 2022 | | 2022 |
James MasonProfessor of Membrane Biochemistry, Institute of Pharmaceutical Science, King's College LondonDirección de correo verificada de kcl.ac.uk
